Introduction
Fibrocystic kidney disease is a common feature in many ciliopathies including Meckel, BardetBiedl and Joubert syndromes (JS) (1, 2) . First described in 1969(3), JS (OMIM 213300) is defined based on a characteristic set of cerebellum and midbrain abnormalities that collectively result in the diagnostic "molar tooth sign" on axial brain images(4) (Figure 1 ). The incidence of JS is estimated to range between 1:80,000 and 1:100,000 (5) . Core clinical features of JS observed shortly after birth include hypotonia and episodic tachypnea and/or apnea, followed later by developmental delay, ocular motor apraxia, truncal ataxia and speech apraxia (5, 6) . Most patients have extra-neurological involvement that can include polydactyly, chorioretinal colobomas, retinal degeneration, congenital hepatic fibrosis, and/or fibrocystic kidney disease (5, 7) . This clinical heterogeneity led to the use of the term Joubert syndrome and related disorders which includes Senior-Løken (nephronophthisis and retinal degeneration) and COACH (colobomas, "oligophrenia" for cognitive impairment, ataxia, cerebellar vermis hypoplasia, and hepatic fibrosis) syndromes (8) . For simplicity, the term JS refers to all patients with the "molar tooth sign" including patients with or without non-neurological disease (6) . In this article, we use JS to include Senior-Løken and COACH syndromes.
Like other syndromic ciliopathies, JS is characterized by extreme genetic heterogeneity, with more than 30 causative genes (5) . The frequency of kidney disease in individual gene-specific subtypes of JS remains unknown; estimates range from 25% to 27% (9, 10) . Most publications on kidney involvement in the disease have been limited to small case series or retrospective multicenter reports based on questionnaires and medical records review (7, 9, (11) (12) (13) . In1992, Saraiva and Baraitser (9) claimed kidney disease and retinal disease in JS were closely linked and only patients with retinal dystrophy were at risk for fibrocystic kidney disease. However, many individuals with JS and kidney disease but no retinal degeneration have since been reported (5, 7) . While the nephronophthisis in Senior-Løken syndrome (14) and cystic dysplastic kidneys in Arima syndrome(7) are relatively well described, the kidney disease in other JS patients is often reported in non-specific terms, noting only absence or presence of "kidney cysts" and neglecting data on features such as blood pressure, kidney function, and delineation of the exact type of the fibrocytic kidney disease. Although many of the over 30 causative JS genes, including CEP290, NPHP1, AHI1, OFD1, RPGRIP1L, CC2D2A, TMEM67, TMEM216, TMEM138, and TMEM237, have been associated with kidney disease, correlations between genotype and kidney disease remain largely unknown (5, 15, 16 ).
Here we describe the characteristics of kidney disease in 97 JS patients prospectively evaluated at a single center. We detail kidney ultrasonography (US), magnetic resonance imaging (MRI) of the kidneys, and kidney function tests in the context of the molecular genetic diagnosis, as well as other organ involvement including liver disease and ophthalmological features. Center. Eight patients from 6 families (including 3 patients with the classical kidney and retina findings of Senior-Løken syndrome) were excluded because they did not have the "molar tooth sign" on our review of their brain MRI images (17) ,.The remaining 97 patients were included in this study.
Materials and Methods

Patients
All patients were evaluated by the last author (MGA); evaluations included past medical history, family history, physical examination, review of past medical records, review of brain magnetic resonance images, high resolution complete abdominal US (all patients), abdominal MRI (13 patients who were able to cooperate for the study without sedation), complete ophthalmologic examination, and comprehensive blood and urine chemistries. Glomerular filtration rate (GFR) was calculated using pediatric (18) and adult (19) formulas. Blood samples for DNA were collected from all patients and parents, when available.
Kidney disease was defined based on GFR and/or abnormal findings on kidney US including increased echogenicity, increased or decreased kidney size, and/or cystic changes. Liver disease was defined by elevated liver enzymes and/or increased echogenicity of the liver and/or splenomegaly on abdominal US. Retinal degeneration was based on typical findings on retinal examination after dilation of pupils. All available brain MR images were qualitatively evaluated by a team of five physicians, including two pediatric neuroradiologists, one adult neuroradiologist, one pediatric neurologist and one pediatric clinical geneticist (MGA), as a group to achieve consensus (17) .
Molecular Inversion Probes (MIP), Whole exome and Sanger Sequencing
The coding exons of 27 genes associated with JS were sequenced by combining a MIP capture method and next-generation sequencing as previously described (20) . In addition, exome sequencing was performed using the HiSeq2000 (Illumina, San Diego, CA)(21) and analyzed as previously described (20) . For further details, please refer to supplementary methods.
Statistical Methods
Ranges, averages and standard deviations were calculated. Serum cystatin C was not available in 4 children (Table 1S , patients 26, 31, 82, and 83), due to problems in handling of blood specimens. For these patients, GFR was calculated using an alternative formula based on height and serum creatinine (22) . Abdominal MRI was performed in 13 of 97 patients who were able to tolerate this study without anesthesia. Therefore, to evaluate kidney size ultrasonography based kidney length which was available on all patients was used. The molecular genetic cause was identified in 19 different JS genes in all but 5 families; detailed molecular genetic findings of this cohort were reported seperately (20) (Table 1S ). Mutations for two-thirds of the families resided in 6 genes: TMEM67 (20%), C5orf42 (14%), CC2D2A (11%), CEP290 (8%), AHI1 (7%), and KIAA0586 (7%). Each of the remaining 13 genes accounted for a small proportion of the families, ranging from 1-6%: MKS1 (6%), INPP5E (4%), NPHP1 (1%),
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RPGRIP1L (1%), TMEM237 (1%), KIAA0753 (1%), and CELSR2 (1%).
Retinal degeneration was detected in 20%, coloboma in 30%, polydactyly in 13%, and liver involvement in 43% (Table 1S ).
Kidney Disease
Kidney involvement was identified in 29 patients; in the remaining 68 patients, kidney US and GFR were normal and there was no hypertension or chronic anemia. (Tables 1 and 2 ). Four patients with kidney disease (Table 2 , patients 9, 16, 53 and 73) underwent kidney transplantation prior to their NIH evaluation. Of the remaining 25 patients with kidney involvement, 24 had abnormalities on kidney US; 13 of these 24 had decreased GFR (Table 2) .
One patient had decreased GFR with normal kidney US.
Kidney Transplantation
At the time this paper was written, 13 of the 29 JS patients with kidney involvement had reached end stage kidney disease (ESRD) at ages 6-24 years (mean 11.3 + 4.8 years); 7 patients have undergone transplantation after their NIH evaluation (Table 2, 
Kidney-related Findings on Prenatal Ultrasonography
Prenatal kidney US was abnormal in only 8 (28%) of the 29 patients with kidney disease (Table   2 , patients 5, 8, 13, 50, 53, 56, 72 and 89). In 2 other affected individuals (Table 1S, patients 17 and 42) prenatal US was normal, but their mothers had other affected pregnancies with enlarged diffusely cystic kidneys resulting in fetal demise. In 4 patients (Table 2, patients 5, 8, 13, and 89), enlarged, hyperechogenic kidneys with or without discrete cysts and/or oligohydramnios were seen at gestational age 19-20 weeks. The mother of patient 5 had another pregnancy with similar US findings at 19 weeks. In patient 53, who required kidney transplantation at age 9 years, prenatal US at 19 weeks showed hyperechogenic kidneys that returned to normal on repeat US in the third trimester. Patient 72 had polyhydramnios during the 8th month of pregnancy. In patient 3, prenatal US was normal but oligohydramnios was diagnosed at delivery and the infant's kidneys were palpable at birth. In 2 patients (50 and 56), the kidney abnormality was unilateral; US at the 20 th week of gestation in each infant showed left multi-cystic dysplastic kidney (MCDK) and the right kidney was normal.
Kidney Imaging Findings at the NIH Clinical Center
The most common abnormality on kidney US was increased echogenicity involving both cortex and medulla, resulting in loss of corticomedullary differentiation with or without discrete cysts (11 of 24 patients with abnormal US). In 5 of these 11 patients (Table 2 , patients 3, 5, 8, 13, and 89), the kidneys were perinatally enlarged; 1 of these patients still had enlarged kidneys at the time of NIH evaluation at age 8 years (Table 2 , patient13). In the remaining 4 kidney sized normalized or became smaller over time ( Figure 2A and B). Patient 60 with left multicystic dysplastic kidney, had an enlarged right kidney likely due to compensatory hypertrophy; in the remaining 24 patients with kidney disease kidney size was either normal or small (Table 2 ). In 4 patients ( Table 2 , patients 40, 52, 54, and 79) cysts and/or hyperechogenicity were confined to medulla ( Figure 2D ). Asymmetric kidney disease was identified in 4 patients ( Table 2, Patient 59's yearly US examinations between ages 1 to 7 were completely normal. At age 7 years, the only abnormal finding was a small cortical cyst at upper pole of left kidney; annual US imaging between ages 7 and 13 remained otherwise normal. At age 17 years, both kidneys were hyperechogenic; left kidney (length at -0.7 SD) had several large cysts in upper pole while right kidney was relatively larger (length at +1.9 SD) with a few small cortical cysts.
Kidney Histopathology Findings
Histopathology of 3 kidney explants (Table 2 , patients 8, 9, and 16) showed severe tubular atrophy, interstitial fibrosis, chronic inflammation, variable degrees of glomerulosclerosis, nephrocalcinosis as well as cysts, mostly accumulated at the CM junction but also scattered throughout the cortex and medulla.
Early-onset Hypertension
Of the 29 patients with kidney disease, 7 had early-onset hypertension diagnosed shortly after birth or within the first years of life, before any measurable decrease in GFR (Table 2 ). Patient 9 was screened at age 3 years after his sister's diagnosis of "polycystic kidneys"; he had cardiomyopathy secondary to undiagnosed early-onset severe hypertension which resolved after treatment.
Discussion
The frequency of kidney disease in our JS cohort was 30%, slightly higher than published estimates of 25 to 27 % (9, 10), perhaps a reflection of our comprehensive evaluations performed specifically to detect kidney disease. The percentage of individuals with kidney disease may also increase with age; our cohort's mean age was 9 years.
Nephronophthisis was present in 31 % of our JS patients with kidney disease, and it resembled the kidney disease of non-syndromic nephronophthisis (23, 24) . Clinically, kidney size was normal or small, with increased echogenicity and a few cysts at the corticomedullary junction. Of the 9 JS patients with nephronophthisis, 2 had Senior-Løken syndrome with retinal degeneration due to mutations in CEP290, andINPP5E; the 7 nephronophthisis patients with no retinal disease had mutations in CC2D2A, TMEM67 and NPHP1.
A hybrid ARPKD-nephronophthisis pattern of kidney disease was present in 35% of JS patients with kidney disease. One characteristic feature of ARPKD(25) but not nephronophthisis (24), present in 7 patients, was early-onset severe hypertension (before any decrease in GFR). Another feature of ARPKD, enlarged kidneys, was seen in 5 patients, making the early differentiation of JS and ARPKD challenging. In fact, 3 patients (8, 9 and 13) were originally diagnosed as having ARPKD and carried this diagnosis until their NIH evaluation under our ARPKD study at ages 6, 9 and 8 years, (respectively); at that time, their mild oculomotor apraxia and developmental delays made us suspect JS. An additional patient, (patient 3) was misdiagnosed as having ARPKD in addition to his known diagnosis of JS, which was the cause of his polycystic kidneys.
Before making a prenatal diagnosis of ARPKD, cerebellar abnormalities and polydactyly should be excluded because renal disease in JS is indistinguishable from ARPKD. Only 13% of JS patients have polydactyly (Table 1) , so a careful evaluation for brain anomalies is essential for prenatal differentiation of JS from ARPKD. In addition, if a child diagnosed as having ARPKD manifests developmental delay and/or ocular motor apraxia, a brain MRI should be performed because patients with JS with mild cerebellar involvement may be misdiagnosed as ARPKD.
The combination of coloboma, kidney disease and polydactyly strongly suggests a ciliopathy, specifically JS. Molecular studies can also be helpful, since 7 of the 10 patients in the ARPKDnephronophthisis group had mutations in TMEM67 and enlarged, ARPKD-like kidneys; indeed, mutations in TMEM67 also cause Meckel syndrome, another ciliopathy with cystic kidney disease(1).
Our most surprising finding was unilateral MCKD in 3 JS patients (50, 56 and 60), two of whom had a completely normal contralateral kidney and normal GFR at ages 3 (patient 56) and 20 years (patient 60) ( Figure 2E and F, Table 2 ). Both of these patients had mutations in AHI1.
While unilateral MCDK occurs as part of many syndromes, asymmetric kidney disease is unexpected in ciliopathies (1, 23) . We are aware of MCDK reported in JS in the medical literature: one Iranian patient with JS and right-sided MCDK (26) , and one with either unilateral kidney agenesis(7) or unilateral MCDK misdiagnosed as kidney agenesis due to resolution of the atrophic kidney (27) . Of note, patient 60 in our cohort was part of a previously reported series (family K8062) (28) . Recently, mutations in HNF1β and TBX18 have been identified in rare families with MCDK (29, 30) , (31) . Our patients, however, had mutations in CEP290 and AHI1 as single gene causes of syndromic MCDK associated with JS.
Modifier genes may influence the occurrence of kidney disease in JS (32) . All 11sibling sets evaluated at NIH were concordant for kidney disease. However, in two families, there was history of a deceased sibling who was discordant for presence of kidney disease (Table 1S and   Table 3 , families 34, and 66). In family 34 (Table 1S) This discrepancy in prenatal detection rates of kidney disease of patients with JS and BardetBiedl syndromes may be due to the variation in the expertise of the prenatal ultrasonography specialists as well as differences in the nature of kidney disease among different ciliopathies.
We can derive several important conclusions from this study. First, kidney disease affects up to one-third of JS patients, and is more common in those with pathogenic variants in CEP290, TMEM67 and AHI1 genes; it was not observed in patients with mutations in C5orf42 or KIAA0586. Second, the severity and progression of kidney disease appeared comparable across JS genotypes, with most patients requiring kidney transplantation in childhood-young adulthood. Patients are grouped by gene and within each gene patients are sorted from the youngest to oldest. US: renal ultrasonography; SD: standard deviation; GFR: glomerular filtration rate; CMD:corticomedullary differentiation; NP: not performed; NPHP: nephronophthisis; ARPKD: autosomal recessive polycystic kidney disease; *Kidney ultrasonography findings are bilateral unless otherwise specified ¥Hypertension diagnosed before any decrease in GFR. Tx( ): Transplanted(age at transplantation in years); £ ( )These patients received renal transplantation after the NIH visit, ages at transplanation in years are indicated in parenthesis. π: This patient (290) reached ESRD at age 5 and was on peritoneal dialysis for 2 years. ¥ MRI based kidney volumes. 
